Doxazosin
- Product NDC
- 58657-823
- 11-digit product format
- 586570823
- Labeler code
- 58657
- Product ID
- 58657-823_eda1b836-6011-bad4-e053-2a95a90a8662
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Method Pharmaceuticals, LLC
- Application
- ANDA212727
- Marketing category
- ANDA
- Marketing start
- 2022-06-01
- Marketing end
- 0000-00-00
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 8 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 58657-823-01 | 58657082301 | 100 TABLET in 1 BOTTLE (58657-823-01) | 100 tablet | 2022-06-01 | 0000-00-00 | No | No | Current |